Lung-Ji Chang

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 5

Top Topics

Acute Lymphoblastic Leukemia

Top Venues

Molecular medicine (Cambridge, Mass.)

Blood cancer journal

This page only lists publications with an associated author ORCID identifier.

Publications

Jie Gong, Rui Yang, Min Zhou, Lung-Ji Chang
Improved intravenous lentiviral gene therapy based on endothelial-specific promoter-driven factor VIII expression for hemophilia A. Molecular medicine (Cambridge, Mass.) 29 (1) (2023)
Jie Gong, Yunyun Liu, Tsai-Hua Chung, Liu Xu, Troy C Lund, Lung-Ji Chang
Intracerebral lentiviral ABCD1 gene therapy in an early disease onset ALD mouse model. Gene therapy (2022)
Cheng-Wei Chang, Yuchen Liu, Cheng Jiao, Hongwei Liu, Jie Gong, Xiaochuan Chen, Lung-Ji Chang
A Glimpse into the Diverse Cellular Immunity against SARS-CoV-2. Vaccines 9 (8) (2021)
Lihua Yu, Lulu Huang, Danna Lin, Xiaorong Lai, Li Wu, Xu Liao, Jiale Liu, Yinghua Zeng, Lichan Liang, Guanmei Zhang, Bin Wang, Zhu Wu, Shaohua Tao, Yuchen Liu, Cheng Jiao, Lung-Ji Chang, Li-Hua Yang
GD2-specific chimeric antigen receptor-modified T cells for the treatment of refractory and/or recurrent neuroblastoma in pediatric patients. Journal of cancer research and clinical oncology (2021)
Cheng Jiao, Eugene Zvonkov, Xun Lai, Rui Zhang, Yuchen Liu, Yue Qin, Valery Savchenko, Nelly Gabeeva, Tsai-Hua Chung, Liyuan Sheng, Lung-Ji Chang
4SCAR2.0: a multi-CAR-T therapy regimen for the treatment of relapsed/refractory B cell lymphomas. Blood cancer journal 11 (3) (2021)